Stefan Hümer
Corporate Officer/Principal bei Channel 21 Holding AG
Profil
Stefan Hümer is currently a Member of the Management Board at Channel 21 Holding AG.
He previously worked as an Investment Controller at Hexal AG, Head of Sales Processing & Salesforce Controlling at Durachemie GmbH and Cyanamid GmbH, and Head of International Controlling at Sandoz International GmbH.
From 2017 to 2020, he served as the Chief Financial Officer at Dermapharm Holding SE.
Aktive Positionen von Stefan Hümer
| Unternehmen | Position | Beginn |
|---|---|---|
Channel 21 Holding AG
 Channel 21 Holding AG Catalog/Specialty DistributionRetail Trade Part of Do it again GmbH, Channel 21 Holding AG is a holding German company that specializes in marketing and selling goods and articles through teleshopping and the Internet. The private company is based in Hannover, Germany. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Stefan Hümer
| Unternehmen | Position | Ende |
|---|---|---|
| DERMAPHARM HOLDING SE | Director of Finance/CFO | 01.07.2020 |
Sandoz International GmbH
 Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Corporate Officer/Principal | - |
Hexal AG
 Hexal AG Pharmaceuticals: MajorHealth Technology H e x a l AG develops, produces, markets and distributes modern generics and medicinal products. Its areas of emphasis are cardiovascular medicinal products, pain therapy medications and gastrointestinal products. The company was founded in April 1986 and is headquartered in Holzkirchen, Germany. | Corporate Officer/Principal | - |
| Cyanamid GmbH | Sales & Marketing | - |
Durachemie GmbH
 Durachemie GmbH Pharmaceuticals: OtherHealth Technology Part of Merck KGaA, Durachemie GmbH is a German company that specializes in medicinal chemicals and botanical products. The company is based in Wolfratshausen, Germany. Durachemie was acquired by Merck KGaA from Wyeth LLC on October 01, 1997. | Sales & Marketing | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| DERMAPHARM HOLDING SE | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Hexal AG
Hexal AG Pharmaceuticals: MajorHealth Technology H e x a l AG develops, produces, markets and distributes modern generics and medicinal products. Its areas of emphasis are cardiovascular medicinal products, pain therapy medications and gastrointestinal products. The company was founded in April 1986 and is headquartered in Holzkirchen, Germany. | Health Technology |
Durachemie GmbH
Durachemie GmbH Pharmaceuticals: OtherHealth Technology Part of Merck KGaA, Durachemie GmbH is a German company that specializes in medicinal chemicals and botanical products. The company is based in Wolfratshausen, Germany. Durachemie was acquired by Merck KGaA from Wyeth LLC on October 01, 1997. | Health Technology |
Sandoz International GmbH
Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Health Technology |
Channel 21 Holding AG
Channel 21 Holding AG Catalog/Specialty DistributionRetail Trade Part of Do it again GmbH, Channel 21 Holding AG is a holding German company that specializes in marketing and selling goods and articles through teleshopping and the Internet. The private company is based in Hannover, Germany. | Retail Trade |
| Cyanamid GmbH |
